A Randomised, Double-Blind, Placebo Controlled, Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers

Trial Profile

A Randomised, Double-Blind, Placebo Controlled, Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 31 May 2016

At a glance

  • Drugs GNbAC1 (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions
  • Sponsors GeNeuro
  • Most Recent Events

    • 21 Apr 2016 Pharmacokinetic and safety data (n=21) presented at the 68th Annual Meeting of the American Academy of Neurology.
    • 19 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 01 Jun 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top